p53 alterations in breast cancer of the Parsi ethnic group

被引:0
|
作者
Abbas, A [1 ]
Kukreti, R [1 ]
Naik, S [1 ]
Therwath, A [1 ]
机构
[1] UNIV PARIS 07,MOL ONCOL LAB,F-75005 PARIS,FRANCE
关键词
breast cancer; SSCP; p53; mutations;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in p53 are the most common genetic abnormality yet found in human cancers. p53 mutations vary among tumor types, ranging from 0-60% in major cancers. The frequency of p53 mutations in breast cancer averages around 25%. The incidence rate and the type of mutations at specific codons seem to be influenced by geographical location as well as racial and ethnic specificities. Women of the Parsi ethnic group living mostly in defined geographical areas around metropolitan Bombay are reported to have a markedly high incidence of breast cancer. In the present work, the p53 gene alterations in the Parsis were investigated using SSCP analysis. The results confirm an earlier observation that over 60% of the Parsi breast tumors harbour p53 alterations. This figure is higher than that observed in other communities. The relevance of the finding in the light of the high breast cancer incidence in the Parsis is discussed.
引用
收藏
页码:401 / 404
页数:4
相关论文
共 50 条
  • [31] P53 MUTATIONS IN BREAST-CANCER
    COLES, C
    CONDIE, A
    CHETTY, U
    STEEL, CM
    EVANS, HJ
    PROSSER, J
    CANCER RESEARCH, 1992, 52 (19) : 5291 - 5298
  • [32] P53 EXPRESSION IN BREAST-CANCER
    CATTORETTI, G
    RILKE, F
    ANDREOLA, S
    DAMATO, L
    DELIA, D
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) : 178 - 183
  • [33] Serum p53 antibody in breast cancer
    Yamamoto, Shinya
    Chishima, Takashi
    Adachi, Shouko
    Harada, Fumi
    Toda, Youko
    Arioka, Hitoshi
    Hasegawa, Naoki
    Kakuta, Yukio
    CANCER BIOMARKERS, 2014, 14 (04) : 203 - 206
  • [34] p53 polymorphism in ovarian and breast cancer
    Campbell, IG
    Eccles, DM
    Dunn, B
    Davis, M
    Leake, V
    LANCET, 1996, 347 (8998): : 393 - 394
  • [35] p53 as a mutagen test in breast cancer
    Hill, KA
    Sommer, SS
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2002, 39 (2-3) : 216 - 227
  • [36] p53 alterations in porokeratosis
    Arranz-Salas, I
    Sanz-Trelles, A
    Bautista-Ojeda, D
    JOURNAL OF CUTANEOUS PATHOLOGY, 2003, 30 (07) : 455 - 458
  • [37] p53 gene alterations are associated with a decreased responsiveness to neoadjuvant chemotherapy in human breast cancer
    LizardNacol, S
    Coudert, B
    Riedinger, JM
    Fargeot, P
    Guerrin, J
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 10 (06) : 1203 - 1207
  • [38] Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer
    F Végran
    R Boidot
    C Oudin
    C Defrain
    M Rebucci
    S Lizard-Nacol
    Oncogene, 2007, 26 : 290 - 297
  • [39] Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer
    Vegran, F.
    Boidot, R.
    Oudin, C.
    Defrain, C.
    Rebucci, M.
    Lizard-Nacol, S.
    ONCOGENE, 2007, 26 (02) : 290 - 297
  • [40] Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
    Amr Ghaleb
    Alisha Yallowitz
    Natalia Marchenko
    Communications Biology, 2